Literature DB >> 21295407

Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia.

Claire Gaveriaux-Ruff1, Chihiro Nozaki, Xavier Nadal, Xavier C Hever, Raphael Weibel, Audrey Matifas, David Reiss, Dominique Filliol, Mohammed A Nassar, John N Wood, Rafael Maldonado, Brigitte L Kieffer.   

Abstract

Opioid receptors are major actors in pain control and are broadly distributed throughout the nervous system. A major challenge in pain research is the identification of key opioid receptor populations within nociceptive pathways, which control physiological and pathological pain. In particular, the respective contribution of peripheral vs. central receptors remains unclear, and it has not been addressed by genetic approaches. To investigate the contribution of peripheral delta opioid receptors in pain control, we created conditional knockout mice where delta receptors are deleted specifically in peripheral Na(V)1.8-positive primary nociceptive neurons. Mutant mice showed normal pain responses to acute heat and to mechanical and formalin stimuli. In contrast, mutant animals showed a remarkable increase of mechanical allodynia under both inflammatory pain induced by complete Freund adjuvant and neuropathic pain induced by partial sciatic nerve ligation. In these 2 models, heat hyperalgesia was virtually unchanged. SNC80, a delta agonist administered either systemically (complete Freund adjuvant and sciatic nerve ligation) or into a paw (sciatic nerve ligation), reduced thermal hyperalgesia and mechanical allodynia in control mice. However, these analgesic effects were absent in conditional mutant mice. In conclusion, this study reveals the existence of delta opioid receptor-mediated mechanisms, which operate at the level of Na(V)1.8-positive nociceptive neurons. Delta receptors in these neurons tonically inhibit mechanical hypersensitivity in both inflammatory and neuropathic pain, and they are essential to mediate delta opioid analgesia under conditions of persistent pain. This delta receptor population represents a feasible therapeutic target to alleviate chronic pain while avoiding adverse central effects. The conditional knockout of delta-opioid receptor in primary afferent Na(V)1.8 neurons augmented mechanical allodynia in persistent pain models and abolished delta opioid analgesia in these models.
Copyright © 2010 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21295407     DOI: 10.1016/j.pain.2010.12.031

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  66 in total

Review 1.  Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.

Authors:  Claire Gavériaux-Ruff; Brigitte Lina Kieffer
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

Review 2.  G Protein-coupled Receptor Biased Agonism.

Authors:  Sima Y Hodavance; Clarice Gareri; Rachel D Torok; Howard A Rockman
Journal:  J Cardiovasc Pharmacol       Date:  2016-03       Impact factor: 3.105

Review 3.  Functional selectivity of GPCR signaling in animals.

Authors:  Lei Zhou; Laura M Bohn
Journal:  Curr Opin Cell Biol       Date:  2013-12-22       Impact factor: 8.382

4.  Ligand- and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists.

Authors:  Iness Charfi; Karim Nagi; Ouissame Mnie-Filali; Dominic Thibault; Gianfranco Balboni; Peter W Schiller; Louis-Eric Trudeau; Graciela Pineyro
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.261

5.  Mice lacking δ-opioid receptors resist the development of diet-induced obesity.

Authors:  Traci A Czyzyk; Amparo Romero-Picó; John Pintar; Jaime H McKinzie; Matthias H Tschöp; Michael A Statnick; Ruben Nogueiras
Journal:  FASEB J       Date:  2012-05-16       Impact factor: 5.191

6.  The cytochrome P450 2D6*10 genetic polymorphism alters postoperative analgesia.

Authors:  Xiao-Bin Wei; Xi Xiao; Zhou-Xin Han; Dan-Qin Lin; Ping Yu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

7.  Zinc alleviates pain through high-affinity binding to the NMDA receptor NR2A subunit.

Authors:  Chihiro Nozaki; Angela Maria Vergnano; Dominique Filliol; Abdel-Mouttalib Ouagazzal; Anne Le Goff; Stéphanie Carvalho; David Reiss; Claire Gaveriaux-Ruff; Jacques Neyton; Pierre Paoletti; Brigitte L Kieffer
Journal:  Nat Neurosci       Date:  2011-07-03       Impact factor: 24.884

8.  Delta opioid receptors presynaptically regulate cutaneous mechanosensory neuron input to the spinal cord dorsal horn.

Authors:  Rita Bardoni; Vivianne L Tawfik; Dong Wang; Amaury François; Carlos Solorzano; Scott A Shuster; Papiya Choudhury; Chiara Betelli; Colleen Cassidy; Kristen Smith; Joriene C de Nooij; Françoise Mennicken; Dajan O'Donnell; Brigitte L Kieffer; C Jeffrey Woodbury; Allan I Basbaum; Amy B MacDermott; Grégory Scherrer
Journal:  Neuron       Date:  2014-02-27       Impact factor: 17.173

9.  The Peripheral Versus Central Antinociception of a Novel Opioid Agonist: Acute Inflammatory Pain in Rats.

Authors:  Mihály Balogh; Zoltán S Zádori; Bernadette Lázár; Dávid Karádi; Szilvia László; Shaaban A Mousa; Sándor Hosztafi; Ferenc Zádor; Pál Riba; Michael Schäfer; Susanna Fürst; Mahmoud Al-Khrasani
Journal:  Neurochem Res       Date:  2018-05-03       Impact factor: 3.996

10.  δ-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice.

Authors:  Amynah A Pradhan; Monique L Smith; Jekaterina Zyuzin; Andrew Charles
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.